465 related articles for article (PubMed ID: 16638847)
1. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
[TBL] [Abstract][Full Text] [Related]
2. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
[TBL] [Abstract][Full Text] [Related]
3. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
4. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
5. [Relation of nerve growth factor expression with perineural invasion and pain in pancreatic cancer].
Hua ZM; Li Z; Lou DL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1251-3. PubMed ID: 16939930
[TBL] [Abstract][Full Text] [Related]
6. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
7. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
8. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
10. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
Dai H; Li R; Wheeler T; Ozen M; Ittmann M; Anderson M; Wang Y; Rowley D; Younes M; Ayala GE
Hum Pathol; 2007 Feb; 38(2):299-307. PubMed ID: 17097719
[TBL] [Abstract][Full Text] [Related]
11. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
13. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
[TBL] [Abstract][Full Text] [Related]
14. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
15. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.
Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Haraguchi N; Inoue H; Murayama S; Mori M
Int J Oncol; 2006 Mar; 28(3):705-13. PubMed ID: 16465376
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of synuclein-gamma in pancreatic adenocarcinoma.
Li Z; Sclabas GM; Peng B; Hess KR; Abbruzzese JL; Evans DB; Chiao PJ
Cancer; 2004 Jul; 101(1):58-65. PubMed ID: 15221989
[TBL] [Abstract][Full Text] [Related]
18. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
Ben QW; Wang JC; Liu J; Zhu Y; Yuan F; Yao WY; Yuan YZ
Ann Surg Oncol; 2010 Aug; 17(8):2213-21. PubMed ID: 20162456
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
20. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
